BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38375048)

  • 1. Effects of Xiaoyao San on exercise capacity and liver mitochondrial metabolomics in rat depression model.
    Zhao W; Ji C; Zheng J; Zhou S; Tian J; Han Y; Qin X
    Chin Herb Med; 2024 Jan; 16(1):132-142. PubMed ID: 38375048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the potential link between antidepressant effect of Xiaoyao San and its pharmacological activity of hepatoprotection based on multi-platform metabolomics.
    Chen C; Yin Q; Tian J; Gao X; Qin X; Du G; Zhou Y
    J Ethnopharmacol; 2020 Mar; 249():112432. PubMed ID: 31790818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique insight for Xiaoyao San exerts antidepressant effects by modulating hippocampal glucose catabolism using stable isotope-resolved metabolomics.
    Wu WZ; Ling-Hu T; Zhao YH; Zhao WD; Ji C; Tian JS; Ren Y; Qin XM
    J Ethnopharmacol; 2023 Jan; 300():115702. PubMed ID: 36099982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the kynurenine metabolism pathway by Xiaoyao San and the underlying effect in the hippocampus of the depressed rat.
    Wang J; Li X; He S; Hu L; Guo J; Huang X; Hu J; Qi Y; Chen B; Shang D; Wen Y
    J Ethnopharmacol; 2018 Mar; 214():13-21. PubMed ID: 29217494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics analysis of the antidepressant prescription Danzhi Xiaoyao Powder in a rat model of Chronic Unpredictable Mild Stress (CUMS).
    Zhu YL; Li SL; Zhu CY; Wang W; Zuo WF; Qiu XJ
    J Ethnopharmacol; 2020 Oct; 260():112832. PubMed ID: 32387465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of Xiaoyao San in treatment of depression,breast hyperplasia,and functional dyspepsia based on network pharmacology].
    Wei FX; Liu HL; Fan YH; Li XQ; Zhao SJ; Qin XM; Liu XJ
    Zhongguo Zhong Yao Za Zhi; 2021 Aug; 46(16):4230-4237. PubMed ID: 34467737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Xiaoyao San in treating non-alcoholic fatty liver disease with liver depression and spleen deficiency: based on bioinformatics, metabolomics and
    Ruan X; Zhang X; Liu L; Zhang J
    J Biomol Struct Dyn; 2024 Jul; 42(10):5128-5146. PubMed ID: 37440274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synergistic anti-depression effects of different efficacy groups of Xiaoyaosan as demonstrated by the integration of network pharmacology and serum metabolomics.
    Liu XJ; Wang YZ; Wei FX; Lv M; Qu P; Chen SJ; Li SY; Qin X
    J Pharm Biomed Anal; 2021 Apr; 197():113949. PubMed ID: 33618131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable Isotope Tracer Technique and Network Pharmacology to Reveal Antidepressant Targets and Active Components of Xiaoyao San.
    Tian J; Wang X; Wu W; Zhao Y; Ling-Hu T; Qin X
    Chem Biodivers; 2024 Apr; 21(4):e202301736. PubMed ID: 38451006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma metabolomics reveals the intervention mechanism of different types of exercise on chronic unpredictable mild stress-induced depression rat model.
    Liu X; Zhang B; Tian J; Han Y
    Metab Brain Dis; 2024 Jan; 39(1):1-13. PubMed ID: 37999885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating Metabolomics and Network Pharmacology to Explore the Mechanism of Xiao-Yao-San in the Treatment of Inflammatory Response in CUMS Mice.
    Zhang Y; Li XJ; Wang XR; Wang X; Li GH; Xue QY; Zhang MJ; Ao HQ
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway.
    Li M; Zhang W; Yang L; Wang H; Wang Y; Huang K; Zhang W
    Dis Markers; 2021; 2021():4304507. PubMed ID: 34306252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry.
    Gao X; Zheng X; Li Z; Zhou Y; Sun H; Zhang L; Guo X; Du G; Qin X
    J Ethnopharmacol; 2011 Sep; 137(1):690-9. PubMed ID: 21718771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Xiaoyaosan on Depressive-Like Behaviors in Rats With Chronic Unpredictable Mild Stress Through HPA Axis Induced Astrocytic Activities.
    Song M; Zhang J; Li X; Liu Y; Wang T; Yan Z; Chen J
    Front Psychiatry; 2020; 11():545823. PubMed ID: 33192662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the compatibility rules of traditional Chinese medicine prescriptions based on NMR metabolomics: A case study of Xiaoyaosan.
    Liu X; Lv M; Wang Y; Zhao D; Zhao S; Li S; Qin X
    J Ethnopharmacol; 2020 May; 254():112726. PubMed ID: 32135241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xiaoyaosan exerts antidepressant-like effects by regulating the functions of astrocytes and EAATs in the prefrontal cortex of mice.
    Liu Y; Ding XF; Wang XX; Zou XJ; Li XJ; Liu YY; Li J; Qian XY; Chen JX
    BMC Complement Altern Med; 2019 Aug; 19(1):215. PubMed ID: 31412844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xiaoyao San, a Chinese herbal formula, ameliorates depression-like behavior in mice through the AdipoR1/AMPK/ACC pathway in hypothalamus.
    Tang KR; Mo XW; Zhou XY; Chen YY; Liu DD; He LL; Ma QY; Li XJ; Chen JX
    J Integr Med; 2022 Sep; 20(5):442-452. PubMed ID: 35906133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating hippocampal metabolomics and network pharmacology deciphers the antidepressant mechanisms of Xiaoyaosan.
    Liu X; Wei F; Liu H; Zhao S; Du G; Qin X
    J Ethnopharmacol; 2021 Mar; 268():113549. PubMed ID: 33152435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A whole transcriptome profiling analysis for antidepressant mechanism of Xiaoyaosan mediated synapse loss via BDNF/trkB/PI3K signal axis in CUMS rats.
    Meng P; Zhang X; Liu TT; Liu J; Luo Y; Xie MX; Yang H; Fang R; Guo DW; Zhong ZY; Wang YH; Ge JW
    BMC Complement Med Ther; 2023 Jun; 23(1):198. PubMed ID: 37322430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xiaoyaosan ameliorates depressive-like behavior and susceptibility to glucose intolerance in rat: involvement of LepR-STAT3/PI3K pathway in hypothalamic arcuate nucleus.
    Qiu W; Wu Q; Zhang K; Da X; Tang K; Yuan N; Deng L; Wu M; Zhang Y; Quan J; Ma Q; Li X; Chen J
    BMC Complement Med Ther; 2023 Apr; 23(1):116. PubMed ID: 37046230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.